LISA GAMBLE: Open Payments
NPI 1568405983 · MARINA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 38 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $1,289
Food & beverage: $840Education: $450
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $350 |
| Janssen Biotech, Inc. | 8 | $183 |
| SEAGEN INC. | 1 | $100 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 2 | $63 |
| Gilead Sciences, Inc. | 2 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $33 |
| BeOne Medicines USA, Inc. | 1 | $32 |
Products named: KEYTRUDA, DARZALEX, KISQALI, Trodelvy, OJJAARA, CARVYKTI, ZYNLONTA, TEVIMBRA.
Industry payments across CA — which companies pay providers there.
